Production of an Oncolytic Adeno-Associated Virus Containing the Pro-Apoptotic TRAIL Gene Can Be Improved by shRNA Interference
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26020567 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Nicholas Donohue und 4 weiteren Autor:innen. Beteiligte Einrichtung: National Institute for Bioprocessing Research and Training, Foster Avenue, Mount Merrion, Blackrock, A94 X099 Dublin, Ireland. Hauptthemen laut MEDLINE: Dependovirus, TNF-Related Apoptosis-Inducing Ligand, RNA, Small Interfering, Genetic Vectors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCIRD CDC HHS, Enterprise Ireland.
Abstract (Originalsprache)
Recombinant Adeno-associated virus (rAAV) is a popular vector for treating genetic diseases caused by absent or defective genes. rAAVs can be produced that contain a therapeutic transgene, i.e., a correct copy of the affected gene, which is then delivered into target cells. A further application of rAAV is to deliver pro-apoptotic genes such as TNF-related apoptosis-inducing ligand (TRAIL) into cancer cells, leading to tumor regression. However, rAAV production is expensive and insufficient yields may hinder wide-spread adoption especially in systemic conditions. During rAAV production, the therapeutic transgene may be expressed in the producer cell line, and in the case of an oncolytic gene, this would likely lead to cell death thus reducing rAAV yields. Here we demonstrate that expression of TRAIL during rAAV production in HEK293F cells negatively impacts rAAV yield. A shRNA-based strategy was developed to suppress the expression of TRAIL in rAAV-producing cells specifically during the production process. Incorporating a TRAIL-targeting shRNA expression cassette within the backbone of the rAAV genome-encoding plasmid during triple-transfection of HEK293F cells reduced transgene expression and led to a 60% increase in the yield of rAAV-TRAIL compared to controls.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Institute for Bioprocessing Research and Training, Foster Avenue, Mount Merrion, Blackrock, A94 X099 Dublin, Ireland.
- Pharmaron, 12 Estuary Banks, Speke, Liverpool L24 8RB, UK.
- School of Chemical and Bioprocess Engineering, University College Dublin, Belfield, D04 V1W8 Dublin, Ireland.
ORCID-Profile: Nicholas Donohue, Simeng Li, Stefano Boi
Förderung
- NCIRD CDC HHS
- Enterprise Ireland
Zitieren
APA
Donohue, N., Li, S., Boi, S., Rainbow-Fletcher, A., & Barron, N. (2025). Production of an Oncolytic Adeno-Associated Virus Containing the Pro-Apoptotic TRAIL Gene Can Be Improved by shRNA Interference. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26020567
Vancouver
Donohue N, Li S, Boi S, Rainbow-Fletcher A, Barron N. Production of an Oncolytic Adeno-Associated Virus Containing the Pro-Apoptotic TRAIL Gene Can Be Improved by shRNA Interference. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26020567
BibTeX
@article{Donohue2025,
author = {Donohue, Nicholas and Li, Simeng and Boi, Stefano and Rainbow-Fletcher, Alana and Barron, Niall},
title = {Production of an Oncolytic Adeno-Associated Virus Containing the Pro-Apoptotic TRAIL Gene Can Be Improved by shRNA Interference},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26020567}
}
EUVIMED